Coin2Dose for Type 1 Diabetes
(Coin2Dose Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests if rewards and reminders can help teenagers with type 1 diabetes take their insulin more regularly. The goal is to improve their health by making it easier for them to manage their condition.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the trial involves using an insulin pump, you will likely continue using it as part of your diabetes management.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, since the trial involves adolescents using an insulin pump, it seems likely that participants will continue their current insulin regimen.
What safety data is available for Coin2Dose treatment in Type 1 Diabetes?
The provided research does not directly mention safety data for Coin2Dose or Cash-Only INcentives To promote insulin DOSE engagement. The studies focus on insulin analogs, device safety, glucagon use, and hypoglycemia management, but do not specifically address Coin2Dose. Therefore, no specific safety data for Coin2Dose is available in the provided research.12345
Is Coin2Dose a promising treatment for Type 1 Diabetes?
Yes, Coin2Dose is a promising treatment for Type 1 Diabetes because it uses financial rewards to encourage people to manage their diabetes better. Studies show that offering money can motivate patients to monitor their blood sugar levels more frequently, which is important for managing diabetes effectively.678910
How is the Coin2Dose treatment different from other treatments for type 1 diabetes?
What data supports the idea that Coin2Dose for Type 1 Diabetes is an effective treatment?
The available research shows that using financial incentives, like those in Coin2Dose, can help improve self-monitoring of blood glucose in adolescents with type 1 diabetes. A study found that monetary rewards increased the frequency of checking blood sugar levels, which is important for managing diabetes effectively. This suggests that Coin2Dose can be an effective treatment by encouraging better diabetes management behaviors.6791011
What data supports the effectiveness of the Coin2Dose treatment for Type 1 Diabetes?
Research shows that using financial incentives can help people with diabetes improve their self-management behaviors, like monitoring blood sugar levels more regularly. This suggests that the Coin2Dose treatment, which uses cash incentives, might encourage better insulin use in people with Type 1 Diabetes.6791011
Are You a Good Fit for This Trial?
This trial is for English-speaking teens aged 11-17 with Type 1 Diabetes who use an insulin pump but have a low daily BOLUS score, indicating they're not using enough insulin. They must be diagnosed for at least 6 months. Teens with allergies to CGM adhesives or other chronic conditions like renal disease can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Coin2Dose intervention or standard care for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Coin2Dose
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nemours Children's Clinic
Lead Sponsor